CIK 0001837607
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853940478
- Phone
- +1 949-354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- Open-market buys, last 90 days
- $57,054
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$57,054. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-19 | Sy Jennifer Chief Accounting Officer | Purchase | +153,846 | $0.13 | $20K | 1,655,022 |
| 2026-03-04 | Sy Jennifer PRINCIPAL ACCOUNTING OFFICER | Grant or award | +925,925 | 1,501,176 | ||
| 2026-02-17 | Sy Jennifer PRINCIPAL ACCOUNTING OFFICER | Grant or award | +575,000 | 575,251 | ||
| 2025-05-21 | Sy Jennifer Chief Accounting Officer | Grant or award · Restricted Stock Units | +925,925 | 925,925 | ||
| 2024-08-31 | Sy Jennifer PRINCIPAL ACCOUNTING OFFICER | Grant or award | +18,010 | 18,010 | ||
| 2024-08-31 | Sy Jennifer PRINCIPAL ACCOUNTING OFFICER | Grant or award · Stock Option | +48,063 | 48,063 |
Page 1 of 1 · 6 trades